Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis

被引:103
作者
Radner, Helga [1 ]
Smolen, Josef S. [1 ]
Aletaha, Daniel [1 ]
机构
[1] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, A-1090 Vienna, Austria
关键词
Rheumatoid arthritis; Comorbidity; Physical function; Disability; Disease activity; DISEASE-ACTIVITY; HEALTH SURVEY; DISABILITY; VALIDATION; MORTALITY; IMPROVEMENT; MORBIDITY; TRIAL; INDEX; SF-36;
D O I
10.1093/rheumatology/keq334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. In 380 patients with established RA, we quantified comorbidity levels according to the age-adjusted Charlson Comorbidity Index (CCIA) and functional disability by serial measures of the HAQ over 1 year. In a subset of 185 patients, we assessed quality of life using Short Form-36 (SF-36). To analyse the relationship between comorbidities, different activities of daily living and health status, we divided patients into four subgroups of CCIA and performed analysis of variance (ANOVA) and multivariable general linear regression models adjusted for gender, disease duration and disease activity. Results. ANOVA showed significant (P < 0.03) increase of disability within each domain of HAQ with increasing level of comorbidity. Similar results were observed using the physical component score (P = 0.003) of the SF-36 and its domains, whereas mental component score (P = 0.31) and its domains were unaffected by comorbidities. In a sub-analysis stratifying patients into different levels of disease activity, we found increase in almost all domains of HAQ within respective groups of CCIA. Conclusions. Activities of daily living represented by HAQ are equally affected by comorbidities. More generally, health status was only affected with respect to its physical but not its mental domains.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 35 条
[11]  
Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO
[12]  
2-F
[13]  
Escalante A, 1999, ARTHRITIS RHEUM-US, V42, P1712, DOI 10.1002/1529-0131(199908)42:8<1712::AID-ANR21>3.0.CO
[14]  
2-X
[15]  
Fries JF, 2006, ARTHRITIS RHEUM, V54, pS534
[16]   MEASUREMENT OF PATIENT OUTCOME IN ARTHRITIS [J].
FRIES, JF ;
SPITZ, P ;
KRAINES, RG ;
HOLMAN, HR .
ARTHRITIS AND RHEUMATISM, 1980, 23 (02) :137-145
[17]   Orthopaedic surgery in patients with rheumatoid arthritis over 20 years: prevalence and predictive factors of large joint replacement [J].
Kapetanovic, M. C. ;
Lindqvist, E. ;
Saxne, T. ;
Eberhardt, K. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (10) :1412-1416
[18]   Remission by composite scores in rheumatoid arthritis: are ankles and feet important? [J].
Kapral, Theresa ;
Dernoschnig, Florian ;
Machold, Klaus P. ;
Stamm, Tanja ;
Schoels, Monika ;
Smolen, Josef S. ;
Aletaha, Daniel .
ARTHRITIS RESEARCH & THERAPY, 2007, 9 (04)
[19]   Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study [J].
Keystone, E. C. ;
Genovese, M. C. ;
Klareskog, L. ;
Hsia, E. C. ;
Hall, S. T. ;
Miranda, P. C. ;
Pazdur, J. ;
Bae, S-C ;
Palmer, W. ;
Zrubek, J. ;
Wiekowski, M. ;
Visvanathan, S. ;
Wu, Z. ;
Rahman, M. U. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) :789-796
[20]   Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial [J].
Klareskog, L ;
van der Heijde, D ;
de Jager, JP ;
Gough, A ;
Kalden, J ;
Malaise, M ;
Mola, EM ;
Pavelka, K ;
Sany, J ;
Settas, L ;
Wajdula, J ;
Pedersen, R ;
Fatenejad, S ;
Sanda, M .
LANCET, 2004, 363 (9410) :675-681